BioVie files prospectus supplement for $17.5M ATM offering; already raised $29M

BIOVIE INC.

Filed prospectus supplement on Dec 23, 2022 for up to $17.5M in Class A common stock sales.
As of Dec 20, 2022, issued 3,709,509 shares under existing ATM for net proceeds of $29.0M.
Sales agents are Cantor Fitzgerald & Co. and B. Riley Securities, Inc.
New shares offered under Registration Statement No. 333-252386 via the August 31, 2022 Sales Agreement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.